Menu
Log In
Vol 1_November 25.2025_Newsletter
Search for
Switch skin
Home
About Us
News
Local Dynamics
Global Trends
M&A
Solutions
Business Consulting
Recruitment Solutions
Capability Development
Health Education
Careers
Videos
Thought Leadership
Market Trends
Capability Development
Corporate Wellness
Knowledge
Thought Leadership
Market Trends
Capability Development
Corporate Wellness
Newsletter
Events
Contact
Contact Us
FAQS
Search for
Monday, December 8 2025
Breaking News
Sandoz Finalizes Acquisition of Just-Evotec Biologics EU SAS, Reinforcing Biosimilars Leadership
AstraZeneca’s Dual-Targeting CAR-T Shows Encouraging Efficacy
Crescent and Kelun-Biotech Execute Double Deal to Swap Cancer Asset Rights
Trial Data Opens Door for Earlier Use of Lilly’s BTK Inhibitor
Stroke Recovery: When Every Movement Becomes Hope
Pharma Megamerger: Major Drug Company Unifies $5.5 Billion Biologics Subsidiary
AstraZeneca Expands Amyloidosis Collaboration with Deal Potentially Reaching $780 Million
Major Funding Deal: Therapeutics Company Secures $275 Million Through Drug Royalty Agreement
Minimum Acceptance Threshold Met in Exchange Proposal Between Two Biotech Firms
A New Breakthrough in Duchenne Muscular Dystrophy Treatment: Promising Phase 3 Trial Results
Facebook
LinkedIn
Log In
Sidebar
Switch skin
Vol 1_November 25.2025_Newsletter
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In
